World's Best Scientists 2026 revealed!
Marketa Zvelebil

Marketa Zvelebil

D-Index & Metrics

Biology and Biochemistry

D-Index
64
Citations
15276
World Ranking
9624
National Ranking
166

Marketa Zvelebil publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Marketa Zvelebil sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 124 publications — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Marketa Zvelebil D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Marketa Zvelebil sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 64 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Marketa Zvelebil is affiliated with the University of Basel in Switzerland. Their academic profile includes research contributions in various scientific areas, although specific details on main fields of study, subfields, or topics are not provided.

There is no available information on recent papers, so details about titles, years of publication, and publication venues are not present.

The scientist does not have documented frequent co-authors or recurring publication venues reported in the available data.

No book publications or details regarding publishers associated with their work have been identified.

Information about awards or recognitions linked to Marketa Zvelebil is absent from the data.

This profile reflects the data currently accessible and does not include assessments or evaluations of their work.

Best Publications

  • The Identification of 2-(1H-Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a Potent, Selective, Orally Bioavailable Inhibitor of Class I PI3 Kinase for the Treatment of Cancer†

    Adrian J. Folkes;Khatereh Ahmadi;Wendy K. Alderton;Sonia Alix

  • Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction.

    M P Wymann;G Bulgarelli-Leva;M J Zvelebil;L Pirola

  • Distinct specificity in the recognition of phosphoinositides by the pleckstrin homology domains of dynamin and Bruton's tyrosine kinase.

    K Salim;M J Bottomley;E Querfurth;M J Zvelebil

  • Prediction of protein secondary structure and active sites using the alignment of homologous sequences.

    Markéta J. Zvelebil;Geoffrey J. Barton;William R. Taylor;Michael J.E. Sternberg

  • p110δ, a novel phosphoinositide 3-kinase in leukocytes

    Bart Vanhaesebroeck;Melanie J. Welham;Kei Kotani;Rob Stein

  • Phosphoinositide 3-kinase signalling – which way to target?

    Matthias P Wymann;Marketa Zvelebil;Muriel Laffargue

  • Exploring the specificity of the PI3K family inhibitor LY294002.

    Severine I. Gharbi;Marketa J. Zvelebil;Stephen J. Shuttleworth;Tim Hancox

  • Mechanism of Two Classes of Cancer Mutations in the Phosphoinositide 3-Kinase Catalytic Subunit.

    Nabil Miled;Ying Yan;Wai Ching Hon;Olga Perisic

  • A human phosphatidylinositol 3-kinase complex related to the yeast Vps34p-Vps15p protein sorting system.

    Stefano Volinia;Ritu Dhand;Bart Vanhaesebroeck;Lindsay K. MacDougall

  • Evaluation of two-dimensional differential gel electrophoresis for proteomic expression analysis of a model breast cancer cell system.

    Severine Gharbi;Piers Gaffney;Alice Yang;Marketa J. Zvelebil

  • Identification of a Disease-Defining Gene Fusion in Epithelioid Hemangioendothelioma

    Munir R. Tanas;Andrea Sboner;Andre M. Oliveira;Michele R. Erickson-Johnson

  • Cloning of a human phosphoinositide 3-kinase with a C2 domain that displays reduced sensitivity to the inhibitor wortmannin.

    Jan Domin;Françoise Pages;Stefano Volinia;Susan E. Rittenhouse

  • iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53.

    Daniele Bergamaschi;Yardena Samuels;Yardena Samuels;Yardena Samuels;Alexandra Sullivan;Marketa Zvelebil

  • A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC

    Charis Eng;D. P. Smith;L. M. Mulligan;C. S. Healey

  • IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-kappaB as well as cell survival and oncogenesis.

    Mads Gyrd-Hansen;Maurice Darding;Maria Miasari;Massimo M. Santoro;Massimo M. Santoro

  • Phosphorylation Regulates Tau Interactions with Src Homology 3 Domains of Phosphatidylinositol 3-Kinase, Phospholipase Cγ1, Grb2, and Src Family Kinases

    C. Hugh Reynolds;Claire J. Garwood;Selina Wray;Caroline Price

  • Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties.

    Martin J. Page;Bob Amess;R. Reid Townsend;Raj Parekh

  • Transcriptome analysis of mammary epithelial subpopulations identifies novel determinants of lineage commitment and cell fate

    Howard Kendrick;Joseph Regan;Fiona-Ann Magnay;Anita Grigoriadis

  • Perforin is activated by a proteolytic cleavage during biosynthesis which reveals a phospholipid‐binding C2 domain

    Ruth Uellner;Marketa J. Zvelebil;Jean Hopkins;Jane Jones

  • Class II Phosphoinositide 3-Kinases Are Downstream Targets of Activated Polypeptide Growth Factor Receptors

    Alexandre Arcaro;Marketa J. Zvelebil;Christian Wallasch;Axel Ullrich

Frequent Co-Authors

Michael D. Waterfield
Michael D. Waterfield Ludwig Cancer Research
Alan Ashworth
Alan Ashworth University of California, San Francisco
Christopher J. Lord
Christopher J. Lord Institute of Cancer Research
Alan Mackay
Alan Mackay Institute of Cancer Research
Rainer Cramer
Rainer Cramer University of Reading
Nick Orr
Nick Orr Queen's University Belfast
Clare M. Isacke
Clare M. Isacke Institute of Cancer Research
Mitch Dowsett
Mitch Dowsett Breast Cancer Research Foundation
Matthias P. Wymann
Matthias P. Wymann University of Basel
Janet M. Thornton
Janet M. Thornton European Bioinformatics Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Students interested in Biology and Biochemistry often explore interdisciplinary fields such as health information management, medical coding, or billing. These roles blend scientific knowledge with data organization, critical for supporting modern healthcare systems.

One key pathway is pursuing a health information management degree. Many programs are available online, making this a flexible option. Graduates can oversee medical records, patient data, and healthcare informatics.

Another popular career involves medical coding and billing. If you're wondering how long does it take to become a medical coder, the answer is typically less than a year with certification programs. These professionals are crucial for accurate healthcare billing and data tracking.

Understanding the distinctions between certifications such as ccs vs cpc is important, as each opens different career routes and salary prospects within coding.

The job outlook for medical billing and coding remains strong, with ongoing demand for skilled professionals. These allied health roles offer stable employment and can complement a bioscience background.

Best Scientists Citing Marketa Zvelebil

Trending Scientists

Recently Published Articles